Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
A Comparison of Alternative Econometric Cost Modeling Techniques
Datos Bibliográficos
| ID | 9103643 |
|---|---|
| Autores | Christopher A Powers (Maryland Dermatology Laser Skin and Vein Institute), Christina Meyer (0000-0003-1270-9968, Maryland Dermatology Laser Skin and Vein Institute), Christina M Meyer, M Christopher Roebuck (0000-0003-4102-4925, Maryland Dermatology Laser Skin and Vein Institute), Baze Vaziri (Maryland Dermatology Laser Skin and Vein Institute) |
| Año | 2005 |
| Volumen | 43 |
| Número | 11 |
| Páginas | 1065-1072 |
| Fecha de publicación | 2005-11-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000182408.54390.00 |
| PMID | 16224298 |
| OpenAlex | W2063820885 |
| Idioma | EN |
| Citas recibidas | 4 |
| Referencias citadas | 24 |
OBJECTIVE: We sought to evaluate several statistical modeling approaches in predicting prospective total annual health costs (medical plus pharmacy) of health plan participants using Pharmacy Health Dimensions (PHD), a pharmacy claims-based risk index. METHODS: We undertook a 2-year (baseline year/follow-up year) longitudinal analysis of integrated medical and pharmacy claims. Included were plan participants younger than 65 years of age with continuous medical and pharmacy coverage (n = 344,832). PHD drug categories, age, gender, and pharmacy costs were derived across the baseline year. Annual total health costs were calculated for each plan participant in follow-up year. Models examined included ordinary least squares (OLS) regression, log-transformed OLS regression with smearing estimator, and 3 two-part models using OLS regression, log-OLS regression with smearing estimator, and generalized linear modeling (GLM), respectively. A 10% random sample was withheld for model validation, which was assessed via adjusted r, mean absolute prediction error, specificity, and positive predictive value. RESULTS: Most PHD drug categories were significant independent predictors of total costs. Among models tested, the OLS model had the lowest mean absolute prediction error and highest adjusted r. The log-OLS and 2-part log-OLS models did not predict costs accurately as the result of issues of log-scale heteroscedasticity. The 2-part model using GLM had lower adjusted r but similar performance in other assessment measures compared with the OLS or 2-part OLS models. CONCLUSION: The PHD system derived solely from pharmacy claims data can be used to predict future total health costs. Using PHD with a simple OLS model may provide similar predictive accuracy in comparison to more advanced econometric models
Econometrics · Economics · Family medicine · Health care · Heteroscedasticity · Linear regression · Ordinary least squares · Predictive modelling · Regression analysis · Statistics · Chronic Disease Management Strategies · Demography · Health Systems, Economic Evaluations, Quality of Life · Mathematics · Medication Adherence and Compliance · Medicine · Pharmacy
Risk Adjustment for Health Care Financing in Chronic Disease
Predicting Healthcare Utilization Using a Pharmacy-based Metric With the WHO’s Anatomic Therapeutic Chemical Algorithm
Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients
Mothers of Children Diagnosed With Attention-Deficit/Hyperactivity Disorder
A Simple Test for Heteroscedasticity and Random Coefficient Variation
Diagnostics for heteroscedasticity in regression
Smearing Estimate
Much ado about two
Too much ado about two-part models and transformation?
Estimating log models
The logged dependent variable, heteroscedasticity, and the retransformation problem
Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population
Construction and Characteristics of the RxRisk-V
Improving Risk Adjustment for Medicare Capitated Reimbursement Using Nonlinear Models
Development and Estimation of a Pediatric Chronic Disease Score Using Automated Pharmacy Data
The Medicaid Rx Model
Risk Adjustment Using Automated Ambulatory Pharmacy Data
A Chronic Disease Score with Empirically Derived Weights
Pharmacy Costs Groups
| Obras citantes distintas | 4 |
|---|---|
| Citas por año | 0,24 |
| Intervalo de citas | 2009 - 2017 (9) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 3 |